Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.48 -0.20 (-5.43%)
As of: Oct 1, 2026 · 10:46 AM EDT

Bolt Biotherapeutics (BOLT) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Bolt Biotherapeutics' Depreciation & Amortization (CF) came in at $171,000 for Q2 2026, down 50.7% from $347,000 a year earlier and down 15.8% from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Bolt Biotherapeutics reported Depreciation & Amortization (CF) of $919,000, down 43.0% year-over-year; for FY2025, it came in at $1.29 million, down 27.5% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 16.1% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $1.78 million in FY2024 (-3.9%), $1.85 million in FY2023 (+11.3%), $1.67 million in FY2022 (+39.6%) and $1.19 million in FY2021 (+95.3%).
  • The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q2 2020.
  • Year-over-year, Depreciation & Amortization (CF) has declined for ten consecutive quarters, with an average decline of 28.1% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2021 (growth of 69.8%), and the weakest in Q2 2026 (a decline of 50.7%).
  • Business Quant data shows BOLT's Depreciation & Amortization (CF) at $203,000 (Q1 2026), $255,000 (Q4 2025) and $290,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Bolt Biotherapeutics 7.09 Mn 7.09 Mn - 171,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 171,000.00
Mar 31, 2026 203,000.00
Dec 31, 2025 255,000.00
Sep 30, 2025 290,000.00
Jun 30, 2025 347,000.00
Mar 31, 2025 399,000.00
Dec 31, 2024 426,000.00
Sep 30, 2024 440,000.00
Jun 30, 2024 457,000.00
Mar 31, 2024 458,000.00
Dec 31, 2023 467,000.00
Sep 30, 2023 462,000.00
Jun 30, 2023 458,000.00
Mar 31, 2023 467,000.00
Dec 31, 2022 462,000.00
Sep 30, 2022 439,000.00
Jun 30, 2022 408,000.00
Mar 31, 2022 357,000.00
Dec 31, 2021 361,000.00
Sep 30, 2021 304,000.00
API Access

Bolt Biotherapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BOLT&period=max&api_key=YOUR_API_KEY